Abstract
Increasing numbers of human diseases involve mutations, misexpression or malfunctioning of receptor protein tyrosine kinases (RTK). In particular, human cancers are often characterized by altered RTK function, due to different genetic causes. Identification of the gene expression program triggered by (RTKs) is essential to clarify the molecular basis of their biological activities. Intracellular signals of RTKs are initiated by specific tyrosines which, when autophosphorylated, recruit signal transducers. How the activation of different signaling pathways is translated into a certain pattern of gene expression is currently unknown. Recently, scientists have tried to answer this question applying DNA microarrays technology using wild-type and mutant RTKs transiently stimulated with their cognate growth factors. The transcriptional response to chronic stimulation of cells upon ectopic expression of oncogenic RTKs has also been investigated through DNA microarrays. The results obtained recently in this field, with their possible implication in cancer development and their impact on cancer diagnosis and treatment will be discussed.
Keywords: RTK, oncogene, gene expression profiling, thyroid
Current Genomics
Title: Tyrosine Kinase Receptors Signaling Revealed by Global Expression Profiles: Implications for Cancer Biology
Volume: 6 Issue: 8
Author(s): R. M. Melillo and Massimo Santoro
Affiliation:
Keywords: RTK, oncogene, gene expression profiling, thyroid
Abstract: Increasing numbers of human diseases involve mutations, misexpression or malfunctioning of receptor protein tyrosine kinases (RTK). In particular, human cancers are often characterized by altered RTK function, due to different genetic causes. Identification of the gene expression program triggered by (RTKs) is essential to clarify the molecular basis of their biological activities. Intracellular signals of RTKs are initiated by specific tyrosines which, when autophosphorylated, recruit signal transducers. How the activation of different signaling pathways is translated into a certain pattern of gene expression is currently unknown. Recently, scientists have tried to answer this question applying DNA microarrays technology using wild-type and mutant RTKs transiently stimulated with their cognate growth factors. The transcriptional response to chronic stimulation of cells upon ectopic expression of oncogenic RTKs has also been investigated through DNA microarrays. The results obtained recently in this field, with their possible implication in cancer development and their impact on cancer diagnosis and treatment will be discussed.
Export Options
About this article
Cite this article as:
Melillo M. R. and Santoro Massimo, Tyrosine Kinase Receptors Signaling Revealed by Global Expression Profiles: Implications for Cancer Biology, Current Genomics 2005; 6 (8) . https://dx.doi.org/10.2174/138920205775811452
DOI https://dx.doi.org/10.2174/138920205775811452 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System
Current Stem Cell Research & Therapy The Hypothalamic-Pituitary-Adrenal Axis: What can it Tell us About Stressors?
CNS & Neurological Disorders - Drug Targets Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy
Current Cancer Drug Targets Supplementation of Rosemary Leaves (Rosmarinus officinalis) Powder Attenuates Oxidative Stress, Inflammation and Fibrosis in Carbon Tetrachloride (CCl4) Treated Rats
Current Nutrition & Food Science Radiolabelled Probes Targeting Infection and Inflammation for Personalized Medicine
Current Pharmaceutical Design Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates
Anti-Cancer Agents in Medicinal Chemistry Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome
Current Pharmaceutical Design Imaging Studies in Hypercalcemia
Current Medicinal Chemistry Heterodimeric Amino Acid Transporters: Molecular Biology and Pathological and Pharmacological Relevance
Current Drug Metabolism Smart Electrospun Nanofibers for Controlled Drug Release: Recent Advances and New Perspectives
Current Pharmaceutical Design Abatacept and Glomerular Diseases: The Open Road for the Second Signal as a New Target is Settled Down
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Redox Environment and its Meaning for Breast Cancer Cells Fate
Current Cancer Drug Targets Diagnostic Accuracy of Ultrasound for the Evaluation of Lateral Compartment Lymph Nodes in Papillary Thyroid Carcinoma
Current Medical Imaging Preclinical Models of Multiple Sclerosis: Advantages and Limitations Towards Better Therapies
Current Medicinal Chemistry Therapeutic Immunoconjugates. Which Cytotoxic Payload: Chemotherapeutic Drug (ADC) or Radionuclide (ARC) ?
Current Cancer Therapy Reviews Osteopontin: An Effector and an Effect of Tumor Metastasis
Current Molecular Medicine Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Current Cancer Drug Targets Molecular and Cellular Regulators of Cancer Angiogenesis
Current Cancer Drug Targets Anticancer Peptides and Proteins: A Panoramic View
Protein & Peptide Letters AKT: A Potential Target for Thyroid Cancer Therapy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders